3.54
+0.11(+3.21%)
Currency In USD
Previous Close | 3.43 |
Open | 3.5 |
Day High | 3.59 |
Day Low | 3.43 |
52-Week High | 5.92 |
52-Week Low | 0.52 |
Volume | 547,266 |
Average Volume | 830,151 |
Market Cap | 233M |
PE | -2.68 |
EPS | -1.32 |
Moving Average 50 Days | 4.03 |
Moving Average 200 Days | 2.66 |
Change | 0.11 |
If you invested $1000 in Neuronetics, Inc. (STIM) since IPO date, it would be worth $127.43 as of June 25, 2025 at a share price of $3.54. Whereas If you bought $1000 worth of Neuronetics, Inc. (STIM) shares 5 years ago, it would be worth $1,685.71 as of June 25, 2025 at a share price of $3.54.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Neuronetics Announces Clinical Presence at the 2025 Clinical TMS Society Annual Meeting and Progress in Greenbrook’s Personalized Care Trial Program
GlobeNewswire Inc.
Jun 10, 2025 12:31 PM GMT
NeuroStar, a Silver Sponsor at CTMSS, will also present two posters as part of the Company’s ongoing commitment to clinical innovation and excellenceMALVERN. Pa., June 10, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a vertically inte
Neuronetics Set to Join Russell 2000® and Russell 3000® Indexes
GlobeNewswire Inc.
Jun 02, 2025 8:30 PM GMT
MALVERN, Pa., June 02, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a vertically integrated, commercial stage, medical technology and healthcare company with a strategic vision of transforming the lives of patients whenever and where
Neuronetics Launches First Inaugural National TMS Therapy Awareness Day During Mental Health Awareness Month
GlobeNewswire Inc.
May 14, 2025 12:31 PM GMT
New national awareness day will foster greater understanding of transcranial magnetic stimulation (TMS) treatment The company will celebrate on social media, sharing patient and provider stories that highlight the impact NeuroStar has as a safe, effe